Biotechnology - , ,
Heragen, Inc. is developing a novel genomic based Breast Cancer Recurrence Test. Heragen, Inc. will help physicians and oncologists make educated decisions using a patented technology. Heragen, Inc. is a spin-off from the Breast Cancer Startup Challenge conducted by National Institute of Health (NIH), National Cancer Institute (NCI), Avon Foundation and Center for Advanced Innovation (CAI).